Cancun, Mexico · Mexico
Research profile compiled by Stem Cell Navigator from public sources. Every fact carries a source and a verification status.
Research-backed provider profile. Each recorded fact is labelled Clinic says, Verified, Pending verification or Not disclosed, with the source we checked. Inclusion is not an endorsement and nothing here indicates that a treatment is safe or effective.
This is a research profile, not a provider listing. Stem Cell Navigator recorded what this provider publishes about itself, checked what could be checked against independent sources, and left everything else visibly unverified or not disclosed. Inclusion is not an endorsement.
Every field is asked of every provider in the same way. Where a provider has not published something, that absence is recorded rather than filled in.
Who the provider is and how an international patient reaches them.
No registered legal operating entity is named on the reviewed public pages.
CKM Research, marketed at ckmresearch.com. The provider also has material published under the CKM Stem Cells brand at ckmstemcells.com.
Mexico
Cancun, Quintana Roo
Calle Ciricote 499, 77533 Cancun, Q.R., Mexico, as shown on the current website. Earlier provider material and a Waze place listing show Calle Ciricote 399, L101. The difference is unresolved.
https://www.ckmresearch.com/
The provider states that it supports international patients and helps arrange travel.
Licensing and regulatory position as claimed and as independently checked.
Describes itself as a stem cell therapy clinic and research centre. No hospital affiliation is stated.
COFEPRIS, the Mexican federal health regulator.
No sanitary-licence number, licensed legal entity, SEASS_REGEN entry, responsible sanitary professional or licence scope for the current premises was identified in public sources during this review.
The provider describes itself as COFEPRIS-Certified and says it complies with COFEPRIS guidelines and international standards. Provider claims COFEPRIS certification and compliance; exact licence documentation is pending independent verification.
Official COFEPRIS material defines specific sanitary-licence categories for regenerative medicine (COFEPRIS-09-027) and for stem-cell collection and banking (09-026 A and B), and COFEPRIS maintains a SEASS_REGEN list of establishments using stem cells or regenerative medicine.
Named clinicians responsible for care, and whether credentials were checked.
Dr. Omar Josue Rojas Vazquez. The full name is corroborated by two independent public physician directories.
CKM presents him as Doctor and Stem Cell Specialist. That title is the provider marketing description and is recorded separately from the credential shown in public registers.
The cedula number appears in two independent public directories. The scope of practice for the procedures marketed, and any additional licensing, were not verified in this review.
What the clinic offers, kept separate from any evidence context.
The FAQ describes mesenchymal stem cell (MSC) therapies and NK-cell therapy.
The provider markets exosome therapy and exosome protocols.
No peptide offering is described on the reviewed pages.
No PRP offering is described. An ultrasound-guided intra-articular procedure is referenced under orthopedic care.
The FAQ also references placental protein extract, growth-factor and anti-aging offerings, and a hyperbaric chamber.
Where the biologic comes from and how it is made and tested.
Not stated on the reviewed pages.
No tissue source for the cells used is stated on the reviewed pages.
No donor screening or infectious-disease testing protocol is described.
No processing or culture method is described.
Not stated on the reviewed pages.
No laboratory or third-party manufacturer is named.
No release testing or quality control process is described.
No dose in cells per administration is published.
No viability figure is published.
How treatment is actually administered.
No administration routes are stated other than a reference to ultrasound-guided intra-articular injection for joint procedures.
Not stated on the reviewed pages.
The FAQ describes ultrasound-guided intra-articular procedures taking roughly 30 to 45 minutes under local anaesthetic with minimal recovery.
Not stated on the reviewed pages.
References hyperbaric chamber therapy used alongside stem cell treatment.
Clinic-stated scope only. This section never implies evidence or efficacy.
The provider markets autoimmune conditions, orthopedic and sports injury, neurological conditions and exosome protocols. Its neurological page names stroke, spinal-cord injury, multiple sclerosis, peripheral neuropathy, cerebral palsy, autism and TBI/CTE.
No excluded conditions are stated on the reviewed pages.
The provider states that it supports patients from first contact through the months after treatment and coordinates travel. No clinical eligibility or screening criteria are published.
Sourced evidence context. Kept structurally separate from the Evidence Grade.
The provider cites general third-party peer-reviewed literature on its neurological and autism pages. Those papers are external literature about the field; none of them studied this provider's own product, batch, protocol, dose or patient outcomes.
No trial registry entry tied to this provider was located, despite the "Research" element of the trading name.
References patient success stories. No outcome dataset, measurement method or aggregate result has been published.
No clinical publication, registered trial, abstract or outcome dataset specific to this provider was identified in this research pass.
Process and capability, not a safety assessment.
No contraindications are described on the reviewed pages.
No adverse-event recording or reporting process is described.
The provider states that its support continues for months after treatment. The follow-up schedule, who conducts it and what is measured are not published.
Pricing as disclosed. Absence of a published price is itself recorded.
Not publicly disclosed in the sources reviewed.
References wellness packages and comprehensive plans without describing what they contain.
Not itemised on the reviewed pages.
What a travelling patient needs to plan.
States that travel arrangements are facilitated so the patient can focus on treatment and recovery. Specific transport provision is not described.
No lodging arrangement is described.
Not stated on the reviewed pages.
Transparency Score, Evidence Grade and verification completeness are three separate concepts and are never combined.
This pass reviewed the provider's current public pages, an older provider site, two independent physician directories, a public place listing and official COFEPRIS framework pages. It did not include provider-supplied documents, licence records, laboratory records or any site visit.
Three unresolved items. First, the current site gives Calle Ciricote 499 while earlier provider material and a Waze place listing give Calle Ciricote 399, L101; whether this is a move, a renumbering, a typo or a separate location is unresolved and Navigator has not resolved it independently. Second, the autism page uses the term Signature Cells without defining what the product is. Third, no clinical publication or registered trial specific to this provider was identified.
This profile records what a provider publishes about itself and what independent sources confirm. Stem Cell Navigator does not provide medical advice, diagnosis or treatment, does not endorse any provider, and a recorded claim is not evidence that a treatment works.